Essex of Columbia, MD, has announced a one-year extension of its partnership with the University of Maryland School of Medicine to continue developing the ImSyn optoelectronic image processor for advanced MRI techniques.By using laser optics with
Essex of Columbia, MD, has announced a one-year extension of its partnership with the University of Maryland School of Medicine to continue developing the ImSyn optoelectronic image processor for advanced MRI techniques.
By using laser optics with high-speed digital electronics, the company believes ImSyn could provide video-rate imaging without the use of supercomputers. Essex believes ImSyn could accelerate research and, eventually, clinical use of functional brain mapping, tumor ablation techniques for the breast and brain, and intraoperative image-guided surgery. Essex also plans to use ImSyn in microscopy and radar image processing applications.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.